SG Americas Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50M Buy
391,243
+86,138
+28% +$10.8M 0.06% 283
2025
Q4
$37.2M Buy
305,105
+179,463
+143% +$20.6M 0.05% 287
2025
Q3
$12.6M Sell
125,642
-3,121
-2% -$281K 0.05% 280
2025
Q2
$10.7M Sell
128,763
-84
-0.1% -$6.7K 0.05% 291
2025
Q1
$10.4M Buy
128,847
+22,741
+21% +$2.03M 0.04% 300
2024
Q4
$9.56M Buy
106,106
+46,718
+79% +$4.53M 0.04% 227
2024
Q3
$5.87M Sell
59,388
-4,939
-8% -$485K 0.02% 369
2024
Q2
$5.96M Sell
64,327
-20,547
-24% -$1.84M 0.04% 474
2024
Q1
$8.05M Sell
84,874
-50,396
-37% -$4.68M 0.04% 423
2023
Q4
$12.1M Sell
135,270
-659,863
-83% -$49M 0.13% 175
2023
Q3
$58.1M Buy
795,133
+128,427
+19% +$10.3M 0.78% 17
2023
Q2
$55.5M Buy
666,706
+566,508
+565% +$47.4M 0.47% 26
2023
Q1
$7.64M Buy
100,198
+39,983
+66% +$3.32M 0.1% 169
2022
Q4
$5M Buy
60,215
+35,275
+141% +$2.86M 0.07% 263
2022
Q3
$1.98M Sell
24,940
-62,849
-72% -$5.3M 0.03% 589
2022
Q2
$6.52M Buy
87,789
+75,949
+641% +$5.7M 0.09% 233
2022
Q1
$1.06M Buy
+11,840
New +$1.09M 0.01% 1382
2021
Q4
Sell
-4,284
Closed -$539K 3862
2021
Q3
$539K Buy
4,284
+244
+6% +$31.4K ﹤0.01% 2427
2021
Q2
$547K Sell
4,040
-506,456
-99% -$66.6M ﹤0.01% 1898
2021
Q1
$69.2M Buy
510,496
+506,291
+12,040% +$75.8M 0.43% 41
2020
Q4
$592K Sell
4,205
-848,930
-100% -$109M ﹤0.01% 1859
2020
Q3
$95.1M Buy
853,135
+691,850
+429% +$77.6M 0.9% 27
2020
Q2
$18.1M Sell
161,285
-338,997
-68% -$33.4M 0.2% 111
2020
Q1
$38.7M Buy
+500,282
New +$44.3M 0.52% 40
2019
Q4
Sell
-60,368
Closed -$4.6M 3473
2019
Q3
$4.6M Buy
+60,368
New +$5.02M 0.04% 492
2019
Q1
Sell
-92,935
Closed -$6.67M 3678
2018
Q4
$6.67M Sell
92,935
-472,810
-84% -$38.1M 0.07% 301
2018
Q3
$54.2M Sell
565,745
-411,957
-42% -$39.9M 0.45% 34
2018
Q2
$93.1M Buy
977,702
+600,603
+159% +$55.2M 0.93% 9
2018
Q1
$33.1M Sell
377,099
-10,253
-3% -$936K 0.29% 67
2017
Q4
$32.9M Buy
387,352
+83,730
+28% +$7.01M 0.35% 46
2017
Q3
$26.3M Buy
303,622
+188,106
+163% +$15.1M 0.26% 62
2017
Q2
$8.92M Buy
115,516
+82,698
+252% +$5.87M 0.09% 239
2017
Q1
$2.28M Sell
32,818
-40,300
-55% -$2.71M 0.02% 814
2016
Q4
$4.33M Sell
73,118
-269,151
-79% -$16.6M 0.04% 521
2016
Q3
$22.7M Sell
342,269
-149,892
-30% -$9.27M 0.26% 78
2016
Q2
$26.6M Buy
492,161
+32,334
+7% +$1.77M 0.2% 91
2016
Q1
$23.8M Buy
459,827
+40,149
+10% +$2.09M 0.18% 89
2015
Q4
$29.5M Sell
419,678
-501,500
-54% -$34.2M 0.23% 78
2015
Q3
$57.3M Buy
921,178
+192,646
+26% +$15.2M 0.34% 52
2015
Q2
$61.3M Buy
728,532
+565,362
+346% +$44M 0.44% 32
2015
Q1
$12.3M Buy
163,170
+138,930
+573% +$9.71M 0.08% 201
2014
Q4
$1.51M Sell
24,240
-76,593
-76% -$4.37M 0.01% 1070
2014
Q3
$5.24M Buy
100,833
+11,661
+13% +$595K 0.03% 485
2014
Q2
$4.58M Buy
89,172
+24,342
+38% +$1.1M 0.03% 613
2014
Q1
$3.08M Sell
64,830
-126,495
-66% -$6.48M 0.01% 774
2013
Q4
$8.3M Sell
191,325
-25,035
-12% -$1.04M 0.04% 484
2013
Q3
$9.31M Buy
216,360
+61,071
+39% +$2.47M 0.04% 432
2013
Q2
$5.4M Buy
+155,289
New +$5.46M 0.03% 552

Other funds holding XBI